University of Wisconsin
School of Medicine and Public Health

Nasia Safdar, MD, PhD



MADISON, WI 53705-2221

(608) 263-1545


  • Aga Khan University Medical College, Lahore, Pakistan - MD
  • University of Wisconsin Hospital and Clinics - Residency in Internal Medicine
  • University of Wisconsin Hospital and Clinics - Fellowship in Infectious Disease
  • University of Wisconsin Hospital and Clinics - Fellowship in Women’s Health and Infectious Disease
  • University of Wisconsin Madison - MS in Population Health Sciences
  • University of Wisconsin Madison - Ph.D. in Clinical Research

Professional Activities

Dr. Nasia Safdar is a faculty member in the Division of Infectious Disease within the Department of Medicine and holds affiliate appointments in the Department of Population Health and the Division of Geriatrics, as well as the division of Industrial and Systems Engineering. Dr. Safdar is Vice Chair for Research in the Department of Medicine and the Medical Director of Infection Control at UW Hospital and Clinics. She leads the department in its mission to reduce healthcare-associated infections by identifying, testing, and implementing novel interventions to reduce and prevent healthcare-associated infections (HAI). Because of her work and research in this area, in 2017 Dr. Safdar received a President’s Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. government on outstanding scientists and engineers beginning their independent careers. In 2014, she received the John Q. Sherman Award for Excellence in Patient Engagement. Dr. Safdar is a Fellow of the American College of Physicians and a member of the Society of Internal General Medicine among other professional memberships.

Clinical Specialties

Dr. Safdar’s clinical focus is on healthcare-associated infections, particularly in the acute care setting.

Research Interests

View Dr. Nasia Safdar’s Publications on NCBI My Bibliography

Dr. Safdar’s research broadly focuses on efficacy of novel interventions to prevent and reduce healthcare-associated infection such as the use of probiotics for reducing colonization by methicillin-resistant Staphylococcus aureus and Clostridium difficile and she has ongoing clinical trials in this area. She leads the fecal bacteriotherapy program at UW Hospital and is the principal investigator for a number of ongoing trials assessing fecal microbiota transplantation as an intervention to reduce HAI. Dr. Safdar has received research funding through the Department of Veterans Affairs, the University of Wisconsin Partnership for the Future Program, the Wisconsin Women’s Health Foundation, the John A. Hartford Foundation, the National Institute of Allergy and Infectious Diseases, the Agency for Healthcare Research and Quality, and as a scholar from the National Institute on Aging.